To assess the efficacy and safety of investigational drug administered immediately after radiocephalic arteriovenous fistula (AVF) creation.
The PI of this project was: David Melnick, MD
This project was funded by: Proteon Therapeutics
The term of this project was: June 2016 to February 2017
The number of subjects scanned during this project was: 20